Skip to main content

Advertisement

Log in

Il fenomeno di Raynaud: diagnostica

Raynaud’s phenomenon: diagnosis

  • Published:
Archivio di Ortopedia e Reumatologia

Abstract

Raynaud’s phenomenon (RP) is a vasospastic disorder characterized by episodic color changes of blanching, cyanosis, and hyperaemia in response to cold and/or emotional stress. Although most typically noted in the fingers, circulation of the toes, ears, nose and tongue is also frequently affected. Population studies have shown that RP in adults is more common in women than in men, with prevalence estimates ranging from 4% to 30%. Geographic variations in the prevalence reflect differences in climate.

RP may be a primary or a secondary process. LeRoy and Medsger suggested criteria for primary RP: symmetric attacks, the absence of tissue necrosis, ulceration or gangrene, the absence of a secondary cause, negative antinuclear antibodies, normal nailfold capillaroscopy and a normal erythrocyte sedimentation rate. Among the CTDs, systemic sclerosis has the highest frequency of RP.

Finding a cause for RP requires a knowledge of the patient’s occupational, smoking and drug history, physical examination, nailfold capillaroscopy, routine laboratory tests and autoantibodies. Furthermore, RP should be distinguished from acrocyanosis, a condition characterized by continuous cyanosis of the hands or feet that is worsened by cold temperature.’

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Bibliografia

  1. Wigley FM (2002) Raynaud’s phenomenon. N Engl J Med 347:1001–1008

    Article  PubMed  Google Scholar 

  2. Zeni S, Ingegnoli F (2004) Il fenomeno di Raynaud. Reumatismo 56:79–83

    Google Scholar 

  3. Maricq HR, Weinrich MC (1988) Diagnosis of Raynaud’s phenomenon assisted by color charts. J Rheumatol 15:454–459

    CAS  PubMed  Google Scholar 

  4. Olsen N, Nielsen SL (1978) Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 38:761–764

    Article  CAS  PubMed  Google Scholar 

  5. Weinrich MC, Maricq HR, Keil JE et al (1990) Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 43:1343–1349

    Article  CAS  PubMed  Google Scholar 

  6. Fraenkel L, Zhang Y, Chaisson CE et al (1999) Different factors influencing the expression of Raynaud’s phenomenon in men and women. Arthritis Rheum 42:306–310

    Article  CAS  PubMed  Google Scholar 

  7. Keil JE, Maricq HR, Weinrich MC et al (1991) Demographic, social and clinical correlates of Raynaud phenomenon. Int J Epidemiol 20:221–224

    Article  CAS  PubMed  Google Scholar 

  8. Riera G, Vilardell M, Vaqué J et al (1993) Prevalence of Raynaud’s phenomenon in Raya healthy Spanish population. J Rheumatol 20:66–69

    CAS  PubMed  Google Scholar 

  9. Maricq HR, Carpentier PH, Weinrich MC et al (1997) Geographic variation in the prevalence of Raynaud’s phenomenon: a 5 region comparison. J Rheumatol 24:879–889

    CAS  PubMed  Google Scholar 

  10. Grassi W, Lapadula G, Leardini G, Scarpa R; Gruppo italiano per lo studio del fenomeno di Raynaud (GISFER) (1995) Il fenomeno di Raynaud. Lineamenti clinici e demografici. Reumatismo 47:1–11

    Google Scholar 

  11. Gallo E, Bianchi E, Motta A, Piccolo N (1994) Incidenza del fenomeno di Raynaud in 1920 residenti in Milano. Minerva Cardioangiol 42:65–71

    CAS  PubMed  Google Scholar 

  12. Watson HR, Robb R, Belcher G, Belch JJ (1999) Seasonal variation of Raynaud’s phenomenon secondary to systemic sclerosis. J Rheumatol 26:1734–1737

    CAS  PubMed  Google Scholar 

  13. Brown KM, Middaugh SJ, Haythornthwaite JA, Bielory L (2001) The effects of stress, anxiety and outdoor temperature on the frequency and severity of Raynaud’s attacks: the Raynaud’s Treatment Study. J Behav Med 24:137–153

    Article  CAS  PubMed  Google Scholar 

  14. Jones GT, Herrick AL, Woodham SE et al (2003) Occurrence of Raynaud’s phenomenon in children ages 12–15 years: prevalence and association with other common symptoms. Arthritis Rheum 48:3518–3521

    Article  PubMed  Google Scholar 

  15. Planchon B, Pistorius MA, Beurrier P, De Faucal P (1994) Primary Raynaud’s phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology 45:677–686

    Article  CAS  PubMed  Google Scholar 

  16. Raynaud’s Treatment Study Investigators (2000) Comparison of sustained release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon. Results from a randomised clinical trial with 1 year follow-up. Arch Intern Med 160:1101–1108

    Article  Google Scholar 

  17. Freedman RR, Mayes MD (1996) Familial aggregation of primary Raynaud’s disease. Arthritis Rheum 39:1189–1191

    Article  CAS  PubMed  Google Scholar 

  18. Kallenberg CG (1990) Early detection of connective tissue disease in patients with Raynaud’s phenomenon. Rheum Dis Clin North Am 16:11–30

    CAS  PubMed  Google Scholar 

  19. Matucci Cerinic M, Kahaleh B, LeRoy EC (1996) Vascular involvement in systemic sclerosis. In: Clements PJ, Furst DE (Eds.) Systemic sclerosis, 1st ed. Williams & Wilkins, Baltimore: 153–174

    Google Scholar 

  20. Johnson S, Iazzetta J, Dewar C (2003) Severe Raynaud’s phenomenon with yohimbine therapy for erectile dysfunction. J Rheumatol 30:2503–2505

    PubMed  Google Scholar 

  21. LeRoy EC, Medsger TA (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10:485–488

    CAS  PubMed  Google Scholar 

  22. Spencer-Green G (1998) Outcomes in primary Raynaud phenomenon: a metaanalysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 158:595–600

    Article  CAS  PubMed  Google Scholar 

  23. Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ (1988) Development of connective tissue disease in patients presenting with Raynaud’s phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 47:634–641

    Article  CAS  PubMed  Google Scholar 

  24. Wollersheim H, Thien T, Hoet MH, van Venrooij WJ (1989) The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud’s phenomenon. Eur J Clin Invest 19:535–541

    Article  CAS  PubMed  Google Scholar 

  25. Harper FE, Maricq HR, Turner RE et al (1982) A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report. Am J Med 72:883–888

    Article  CAS  PubMed  Google Scholar 

  26. Zufferey P, Depairon M, Chamot AM, Monti M (1992) Prognostic significance of nailfold capillary microscopy in patients with Raynaud’s phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study. Clin Rheumatol 11:536–541

    Article  CAS  PubMed  Google Scholar 

  27. Faravelli C, Zeni S, Cirla E, Fantini F (1990) Gli autoanticorpi anticentromero e anti-Scl 70 nell’inquadramento diagnostico della sclerodermia. Reumatismo 2:115–124

    Google Scholar 

  28. Luggen M, Belhorn L, Evans T et al (1995) The evolution of Raynaud’s phenomenon: a longterm prospective study. J Rheumatol 22:2226–2232

    CAS  PubMed  Google Scholar 

  29. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum 48:3023–3030

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Zeni, S. Il fenomeno di Raynaud: diagnostica. Arch Ortop Reumatol 121, 10–11 (2010). https://doi.org/10.1007/s10261-010-0004-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10261-010-0004-0

Navigation